10.92
-0.42(-3.70%)
Currency In USD
| Previous Close | 11.34 |
| Open | 11.4 |
| Day High | 11.51 |
| Day Low | 10.85 |
| 52-Week High | 32.75 |
| 52-Week Low | 10.01 |
| Volume | 341,100 |
| Average Volume | 299,801 |
| Market Cap | 400.37M |
| PE | -3.02 |
| EPS | -3.61 |
| Moving Average 50 Days | 12.07 |
| Moving Average 200 Days | 16.64 |
| Change | -0.42 |
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
GlobeNewswire Inc.
Oct 21, 2025 8:05 PM GMT
SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced tha
Medtech Leader Erica Rogers Joins Ceribell Board of Directors
GlobeNewswire Inc.
Sep 22, 2025 12:00 PM GMT
Accomplished innovator and healthcare executive brings proven strategic leadership and expertise in scaling high-growth healthcare companiesSUNNYVALE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell” or the “Comp
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire Inc.
Jul 29, 2025 8:05 PM GMT
SUNNYVALE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced tha